2,N,N-TMT

2,N,N-TMT

File:2,N,N-TMT.svg
Gene therapy
Clinical data
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name (2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine
Chemical and physical data
Formula	C13H18N2
Molar mass	202.30 g/mol

2,N,N-trimethyltryptamine (2,N,N-TMT, 2-Me-DMT, 2-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#34) . It is claimed to show psychoactive effects at a dosage of 50-100mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT_2A receptor target that mediates the hallucinogenic effects of these drugs.